Journal of Cancer Survivorship

, Volume 7, Issue 3, pp 404–412 | Cite as

Potential gonadotoxicity of treatment in relation to quality of life and mental well-being of male survivors of childhood acute lymphoblastic leukemia

  • Mirja Erika Gunn
  • Päivi Maria Lähteenmäki
  • Leena-Riitta Puukko-Viertomies
  • Markus Henriksson
  • Risto Heikkinen
  • Kirsi Jahnukainen



Results of earlier studies concerning quality of life (QOL) and psychosocial coping of childhood acute lymphoblastic leukemia (ALL) survivors have been inconsistent. Some treatments for ALL affect testicular function and we hypothesized that this may influence the QOL and psychosocial coping of male survivors. Our aims were to assess the QOL and psychosocial coping of male long-term ALL survivors and to evaluate the effect of both testosterone level and the potential gonadotoxicity of various treatment modalities on them.


Fifty-two male long-term survivors treated for childhood ALL at Helsinki University Hospital between 1970 and 1995, and 56 age- and gender-matched controls were studied. The participants completed a self-report questionnaire including questions on sociodemographics, RAND-36 to assess QOL, General Health Questionnaire and Beck Depression Inventory to assess mental well-being, and CAGE to assess alcohol abuse/dependence. Testosterone levels were measured, and treatment details were reviewed.


ALL survivors in general had QOL close to that of controls or population norms. Decreased QOL was seen in physical health-related subscales, and vitality and emotional well-being were lowered in survivors with more gonadotoxic treatment modalities. No single independent factor in the treatment or the level of testosterone could, however, be found to clearly explain the variation in QOL scores of the survivors. Mental well-being of most of the survivors was good, but a subgroup with previous cyclophosphamide treatment or testicular irradiation showed increased risk of psychiatric morbidity.


The male ALL survivors generally cope well, but increased focus on specific risk groups seems to be necessary. Further studies using patient interviews would probably point out issues concerning the QOL and psychosocial coping of ALL survivors, which may not emerge in these screening studies.

Implications for Cancer Survivors

In general, more attention should be paid for physical functioning of childhood ALL survivors. Increased focus should also be on QOL and mental well-being of survivors with more gonadotoxic treatment modalities and those whose diagnosis was made in their adolescence.


Acute lymphoblastic leukemia Quality of life Psychosocial Adolescent/young adult Survivorship Testicular function 



We thank Marjut Grainger for statistical assistance. This work was funded by the Foundation of Nona and Kullervo Väre, Children’s Cancer Trust in memoriam of Emilia Heinonen, The National Graduate School of Clinical Investigation, and The Foundation of Wilho Kyttä. Study sponsors had no involvement in the study.

Conflict of interest

The authors have nothing to disclose.


  1. 1.
    Harila MJ, Salo J, Lanning M, Vilkkumaa I, Harila-Saari AH. High health-related quality of life among long-term survivors of childhood acute lymphoblastic leukemia. Pediatr Blood Cancer. 2010;55:331–6.PubMedCrossRefGoogle Scholar
  2. 2.
    Apajasalo M, Sintonen H, Siimes MA, Hovi L, Holmberg C, Boyd H, et al. Health-related quality of life of adults surviving malignancies in childhood. Eur J Cancer. 1996;32A:1354–8.PubMedCrossRefGoogle Scholar
  3. 3.
    Maunsell E, Pogany L, Barrera M, Shaw AK, Speechley KN. Quality of life among long-term adolescent and adult survivors of childhood cancer. J Clin Oncol. 2006;24:2527–35.PubMedCrossRefGoogle Scholar
  4. 4.
    Zeltzer LK, Lu Q, Leisenring W, Tsao JC, Recklitis C, Armstrong G, et al. Psychosocial outcomes and health-related quality of life in adult childhood cancer survivors: a report from the childhood cancer survivor study. Cancer Epidemiol Biomarkers Prev. 2008;17:435–46.PubMedCrossRefGoogle Scholar
  5. 5.
    Goldberg DP, Williams P. A user’s guide to the general health questionnaire. Basingstoke: NFER-Nelson; 1988.Google Scholar
  6. 6.
    Hardy GE, Shapiro DA, Haynes CE, Rick JE. Validation of the general health questionnaire-12: using a sample of employees from England’s health care services. Psychol Assess. 1999;11:159–65.CrossRefGoogle Scholar
  7. 7.
    Beck AT, Rush AJ, Shaw BF. Emery G cognitive therapy of depression. New York: Guilford; 1979.Google Scholar
  8. 8.
    Beck AT, Steer RA, Garbin MG. Psychometric properties of the Beck Depression Inventory: twenty-five years of evaluation. Clin Psychol Rev. 1988;8:77–100.CrossRefGoogle Scholar
  9. 9.
    Holi MM, Marttunen M, Aalberg V. Comparison of the GHQ-36, the GHQ-12 and the SCL-90 as psychiatric screening instruments in the Finnish population. Nord J Psychiatry. 2003;57:233–8.PubMedCrossRefGoogle Scholar
  10. 10.
    Mari JJ, Williams P. A comparison of the validity of two psychiatric screening questionnaires (GHQ-12 and SRQ-20) in Brazil, using relative operating characteristic (ROC) analysis. Psychol Med. 1985;15:651–9.PubMedCrossRefGoogle Scholar
  11. 11.
    Goldberg DP, Gater R, Sartorius N, Ustun TB, Piccinelli M, Gureje O, et al. The validity of two versions of the GHQ in the WHO study of mental illness in general health care. Psychol Med. 1997;27:191–7.PubMedCrossRefGoogle Scholar
  12. 12.
    Ewing JA. Detecting alcoholism. The CAGE questionnaire. JAMA. 1984;252:1905–7.PubMedCrossRefGoogle Scholar
  13. 13.
    Fiellin DA, Reid MC, O’Connor PG. Screening for alcohol problems in primary care: a systematic review. Arch Intern Med. 2000;160:1977–89.PubMedCrossRefGoogle Scholar
  14. 14.
    Hays RD, Sherbourne CD, Mazel RM. The RAND 36-item health survey 1.0. Health Econ. 1993;2:217–27.PubMedCrossRefGoogle Scholar
  15. 15.
    Aalto AM, Aro AR, Teperi J. RAND-36 terveyteen liittyvän elämänlaadun mittarina. Mittarin luotettavuus ja suomalaiset väestöarvot. 1999.Google Scholar
  16. 16.
    Hays RD, Morales LS. The RAND-36 measure of health-related quality of life. Ann Med. 2001;33:350–7.PubMedCrossRefGoogle Scholar
  17. 17.
    Jahnukainen K, Heikkinen R, Henriksson M, Cooper TG, Puukko-Viertomies LR, Makitie O. Semen quality and fertility in adult long-term survivors of childhood acute lymphoblastic leukemia. Fertil Steril. 2011;96:837–42.PubMedCrossRefGoogle Scholar
  18. 18.
    Sundberg KK, Doukkali E, Lampic C, Eriksson LE, Arvidson J, Wettergren L. Long-term survivors of childhood cancer report quality of life and health status in parity with a comparison group. Pediatr Blood Cancer. 2010;55:337–43.PubMedCrossRefGoogle Scholar
  19. 19.
    Wright MJ, Galea V, Barr RD. Proficiency of balance in children and youth who have had acute lymphoblastic leukemia. Phys Ther. 2005;85:782–90.PubMedGoogle Scholar
  20. 20.
    Mackie E, Hill J, Kondryn H, McNally R. Adult psychosocial outcomes in long-term survivors of acute lymphoblastic leukaemia and Wilms’ tumour: a controlled study. Lancet. 2000;355:1310–4.PubMedCrossRefGoogle Scholar
  21. 21.
    Zebrack BJ, Zeltzer LK, Whitton J, Mertens AC, Odom L, Berkow R, et al. Psychological outcomes in long-term survivors of childhood leukemia, Hodgkin’s disease, and non-Hodgkin’s lymphoma: a report from the childhood cancer survivor study. Pediatrics. 2002;110:42–52.PubMedCrossRefGoogle Scholar
  22. 22.
    Harila MJ, Niinivirta TI, Winqvist S, Harila-Saari AH. Low depressive symptom and mental distress scores in adult long-term survivors of childhood acute lymphoblastic leukemia. J Pediatr Hematol Oncol. 2011;33:194–8.PubMedCrossRefGoogle Scholar
  23. 23.
    Frobisher C, Lancashire ER, Reulen RC, Winter DL, Stevens MC, Hawkins MM, et al. Extent of alcohol consumption among adult survivors of childhood cancer: the British childhood cancer survivor study. Cancer Epidemiol Biomarkers Prev. 2010;19:1174–84.PubMedCrossRefGoogle Scholar
  24. 24.
    Temming P, Jenney ME. The neurodevelopmental sequelae of childhood leukaemia and its treatment. Arch Dis Child. 2010;95:936–40.PubMedCrossRefGoogle Scholar
  25. 25.
    Harila-Saari AH, Lahteenmaki PM, Pukkala E, Kyyronen P, Lanning M, Sankila R. Scholastic achievements of childhood leukemia patients: a nationwide, register-based study. J Clin Oncol. 2007;25:3518–24.PubMedCrossRefGoogle Scholar
  26. 26.
    Holmqvist AS, Wiebe T, Hjorth L, Lindgren A, Ora I, Moell C. Young age at diagnosis is a risk factor for negative late socio-economic effects after acute lymphoblastic leukemia in childhood. Pediatr Blood Cancer. 2010;55:698–707.PubMedCrossRefGoogle Scholar
  27. 27.
    Mody R, Li S, Dover DC, Sallan S, Leisenring W, Oeffinger KC, et al. Twenty-five-year follow-up among survivors of childhood acute lymphoblastic leukemia: a report from the childhood cancer survivor study. Blood. 2008;111:5515–23.PubMedCrossRefGoogle Scholar
  28. 28.
    Langeveld NE, Ubbink MC, Last BF, Grootenhuis MA, Voute PA, De Haan RJ. Educational achievement, employment and living situation in long-term young adult survivors of childhood cancer in the Netherlands. Psychooncology. 2003;12:213–25.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2013

Authors and Affiliations

  • Mirja Erika Gunn
    • 1
  • Päivi Maria Lähteenmäki
    • 1
  • Leena-Riitta Puukko-Viertomies
    • 2
  • Markus Henriksson
    • 3
    • 4
  • Risto Heikkinen
    • 2
  • Kirsi Jahnukainen
    • 5
    • 6
  1. 1.Department of PediatricsTurku University HospitalTurkuFinland
  2. 2.Department of Adolescent PsychiatryHelsinki University HospitalHelsinkiFinland
  3. 3.National Supervisory Authority for Welfare and HealthHelsinkiFinland
  4. 4.Centre for Military MedicineFinnish Defence ForcesLahtiFinland
  5. 5.Division of Hematology–Oncology and Stem Cell Transplantation, Children´s HospitalUniversity of Helsinki and Helsinki University Central HospitalHelsinkiFinland
  6. 6.Department of Women’s and Children’s HealthKarolinska Institute and University HospitalStockholmSweden

Personalised recommendations